Hi , Agree outside trader. I am looking to get into cochlear myself but it is not cheap at moment according to the market and does not offer a sufficient margin of safety. I'm really not worried about the Recall, to be quite honest, most medical professionals and patients probably don't even know about it. There are too many other things to worry about in clinical practice than product deficiencies unless the side effects are life threatening. In the absence of a dramatically life changing product from a competitor, cochlear has nothing to worry about IMO. 42 is first support, then 40 , if it dosen't hold, it looks like a long way down. For people wanting to invest in this , value averaging down is probably a way to go. I personally will start from 35. For many this may seem too low a price but it offers a good margin of safety. If I miss out so be it. Many other beaten down stocks.
COH Price at posting:
$46.39 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)